InspireMD, Inc. (NSPR)
USD 2.53
(-5.87%)
USD 2.53
(-5.87%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.8 Million USD | 61.77% |
| 2022 | 1.11 Million USD | 48.14% |
| 2021 | 754 Thousand USD | 808.43% |
| 2020 | 83 Thousand USD | -89.02% |
| 2019 | 756 Thousand USD | -24.02% |
| 2018 | 995 Thousand USD | 70.09% |
| 2017 | 585 Thousand USD | 473.53% |
| 2016 | 102 Thousand USD | 134.46% |
| 2015 | -296 Thousand USD | -137.76% |
| 2014 | 784 Thousand USD | -69.73% |
| 2013 | 2.59 Million USD | 3.6% |
| 2012 | 2.5 Million USD | -16.47% |
| 2011 | 2.99 Million USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 331 Thousand USD | 13.36% |
| 2024 Q1 | 292 Thousand USD | -42.18% |
| 2023 Q1 | 373 Thousand USD | 88.38% |
| 2023 Q3 | 438 Thousand USD | -10.79% |
| 2023 Q4 | 505 Thousand USD | 15.3% |
| 2023 FY | 1.8 Million USD | 61.77% |
| 2023 Q2 | 491 Thousand USD | 31.64% |
| 2022 Q4 | 198 Thousand USD | -45.9% |
| 2022 Q1 | 122 Thousand USD | -58.5% |
| 2022 FY | 1.11 Million USD | 48.14% |
| 2022 Q2 | 431 Thousand USD | 253.28% |
| 2022 Q3 | 366 Thousand USD | -15.08% |
| 2021 Q2 | 262 Thousand USD | 147.17% |
| 2021 Q4 | 294 Thousand USD | 219.57% |
| 2021 FY | 754 Thousand USD | 808.43% |
| 2021 Q1 | 106 Thousand USD | 127.18% |
| 2021 Q3 | 92 Thousand USD | -64.89% |
| 2020 Q3 | 298 Thousand USD | 348.33% |
| 2020 FY | 83 Thousand USD | -89.02% |
| 2020 Q1 | 295 Thousand USD | 13.9% |
| 2020 Q2 | -120 Thousand USD | -140.68% |
| 2020 Q4 | -390 Thousand USD | -230.87% |
| 2019 Q3 | 128 Thousand USD | -71.04% |
| 2019 Q2 | 442 Thousand USD | 705.48% |
| 2019 Q1 | -73 Thousand USD | -132.16% |
| 2019 FY | 756 Thousand USD | -24.02% |
| 2019 Q4 | 259 Thousand USD | 102.34% |
| 2018 Q2 | 277 Thousand USD | -5.46% |
| 2018 Q4 | 227 Thousand USD | 14.65% |
| 2018 Q3 | 198 Thousand USD | -28.52% |
| 2018 FY | 995 Thousand USD | 70.09% |
| 2018 Q1 | 293 Thousand USD | 39.52% |
| 2017 Q3 | 153 Thousand USD | 4.08% |
| 2017 Q4 | 210 Thousand USD | 37.25% |
| 2017 FY | 585 Thousand USD | 473.53% |
| 2017 Q1 | 74 Thousand USD | 232.14% |
| 2017 Q2 | 147 Thousand USD | 98.65% |
| 2016 Q4 | -56 Thousand USD | -280.65% |
| 2016 FY | 102 Thousand USD | 134.46% |
| 2016 Q1 | 66 Thousand USD | 148.53% |
| 2016 Q3 | 31 Thousand USD | -50.0% |
| 2016 Q2 | 62 Thousand USD | -6.06% |
| 2015 FY | -296 Thousand USD | -137.76% |
| 2015 Q3 | 89 Thousand USD | 141.98% |
| 2015 Q4 | -136 Thousand USD | -252.81% |
| 2015 Q2 | -212 Thousand USD | -472.97% |
| 2015 Q1 | -37 Thousand USD | -109.39% |
| 2014 Q2 | -391 Thousand USD | -145.62% |
| 2014 Q3 | -76 Thousand USD | 80.56% |
| 2014 FY | 784 Thousand USD | -69.73% |
| 2014 Q1 | 857 Thousand USD | 0.0% |
| 2014 Q4 | 394 Thousand USD | 618.42% |
| 2013 Q2 | 668 Thousand USD | -20.48% |
| 2013 Q1 | 840 Thousand USD | 4.61% |
| 2013 FY | 2.59 Million USD | 3.6% |
| 2013 Q4 | - USD | -100.0% |
| 2013 Q3 | 802 Thousand USD | 20.06% |
| 2012 Q2 | 530 Thousand USD | -6.03% |
| 2012 Q1 | 564 Thousand USD | -9.18% |
| 2012 FY | 2.5 Million USD | -16.47% |
| 2012 Q4 | 803 Thousand USD | 187.81% |
| 2012 Q3 | 279 Thousand USD | -47.36% |
| 2011 Q1 | 787 Thousand USD | 0.0% |
| 2011 FY | 2.99 Million USD | 0.0% |
| 2011 Q4 | 621 Thousand USD | -47.59% |
| 2011 Q3 | 1.18 Million USD | 196.25% |
| 2011 Q2 | 400 Thousand USD | -49.17% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | 29.137% |
| BrainsWay Ltd. | 23.09 Million USD | 92.174% |
| Cerus Corporation | 86.4 Million USD | 97.909% |
| Envoy Medical, Inc. | -473 Thousand USD | 482.03% |
| electroCore, Inc. | 13.22 Million USD | 86.338% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -2862.295% |
| IceCure Medical Ltd | 1.3 Million USD | -39.0% |
| Inogen, Inc. | 126.69 Million USD | 98.574% |
| OrthoPediatrics Corp. | 111.25 Million USD | 98.376% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 129.868% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 3917.391% |
| MaxCyte, Inc. | 36.54 Million USD | 95.056% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -295.823% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -2024.383% |
| Orthofix Medical Inc. | 486.27 Million USD | 99.628% |
| PAVmed Inc | -3.96 Million USD | 145.539% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 132.944% |
| RxSight, Inc. | 53.76 Million USD | 96.639% |
| Sight Sciences, Inc. | 69.17 Million USD | 97.388% |
| SI-BONE, Inc. | 109.42 Million USD | 98.349% |
| TELA Bio, Inc. | 40.11 Million USD | 95.495% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 98.811% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 78.153% |
| Acutus Medical, Inc. | -3.13 Million USD | 157.603% |
| Talis Biomedical Corporation | 371 Thousand USD | -387.062% |
| Spectral AI, Inc. | 7.88 Million USD | 77.069% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 127.412% |
| CVRx, Inc. | 33.03 Million USD | 94.531% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -144.346% |
| Bioventus Inc. | 328.19 Million USD | 99.449% |
| Venus Concept Inc. | 52.16 Million USD | 96.536% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 88.64% |
| LivaNova PLC | 771.25 Million USD | 99.766% |
| 908 Devices Inc. | 25.32 Million USD | 92.864% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 99.417% |
| Nemaura Medical Inc. | -1.47 Million USD | 222.393% |
| NeuroPace, Inc. | 48.12 Million USD | 96.245% |
| LENSAR, Inc. | 21.1 Million USD | 91.439% |
| Apyx Medical Corporation | 14.12 Million USD | 87.204% |
| Cutera, Inc. | 41.49 Million USD | 95.645% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 90.212% |
| BioSig Technologies, Inc. | 18 Thousand USD | -9938.889% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 98.247% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 86.727% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.797% |
| Axonics, Inc. | 274.55 Million USD | 99.342% |
| Outset Medical, Inc. | 29 Million USD | 93.769% |
| IRIDEX Corporation | 21.8 Million USD | 91.714% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 97.457% |
| IRadimed Corporation | 50.15 Million USD | 96.397% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -529.617% |
| INVO Bioscience, Inc. | 1.08 Million USD | -66.369% |
| Telesis Bio, Inc. | 16.95 Million USD | 89.339% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 98.398% |
| Varex Imaging Corporation | 256.9 Million USD | 99.297% |
| Quipt Home Medical Corp. | 163.84 Million USD | 98.897% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 545.074% |
| Pulmonx Corporation | 50.75 Million USD | 96.44% |
| Dynatronics Corporation | 7.63 Million USD | 76.333% |
| Modular Medical, Inc. | -768 Thousand USD | 335.286% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 67.43% |
| Semler Scientific, Inc. | 61.2 Million USD | 97.047% |
| InMode Ltd. | 411.34 Million USD | 99.561% |
| Bruker Corporation | 1.51 Billion USD | 99.881% |
| Cytosorbents Corporation | 22.39 Million USD | 91.93% |
| DexCom, Inc. | 2.28 Billion USD | 99.921% |
| Align Technology, Inc. | 2.71 Billion USD | 99.934% |
| Viveve Medical, Inc. | 620 Thousand USD | -191.452% |
| ZimVie Inc. | 290.38 Million USD | 99.378% |
| Movano Inc. | -158 Thousand USD | 1243.671% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 98.349% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -2024.383% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 99.509% |
| Profound Medical Corp. | 4.51 Million USD | 59.969% |
| Insulet Corporation | 1.15 Billion USD | 99.844% |
| enVVeno Medical Corporation | -546 Thousand USD | 430.952% |
| Surmodics, Inc. | 93.05 Million USD | 98.058% |
| iCAD, Inc. | 14.53 Million USD | 87.569% |
| Nuwellis, Inc. | 4.98 Million USD | 63.737% |
| Biotricity, Inc. | 8.35 Million USD | 78.376% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 99.455% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 603.263% |
| PAVmed Inc. | -3.96 Million USD | 145.539% |
| BIOLASE, Inc. | 16.72 Million USD | 89.195% |
| Beyond Air, Inc. | -1.3 Million USD | 238.256% |
| FONAR Corporation | 45.14 Million USD | 95.997% |
| AxoGen, Inc. | 127.87 Million USD | 98.587% |
| Vivani Medical, Inc. | -357 Thousand USD | 606.162% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 99.074% |
| Inari Medical, Inc. | 434.56 Million USD | 99.584% |
| UFP Technologies, Inc. | 112.22 Million USD | 98.39% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -14334.06% |
| Tenon Medical, Inc. | 1.24 Million USD | -45.608% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 2330.864% |
| Co-Diagnostics, Inc. | 2.62 Million USD | 31.217% |
| AdaptHealth Corp. | 479.56 Million USD | 99.623% |
| Sintx Technologies, Inc. | 1.84 Million USD | 1.953% |
| NanoVibronix, Inc. | 1.53 Million USD | -17.567% |
| Quanterix Corporation | 70.64 Million USD | 97.442% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 545.074% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 87.148% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 96.576% |
| TransMedics Group, Inc. | 154.09 Million USD | 98.827% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 59.421% |
| NeuroMetrix, Inc. | 3.94 Million USD | 54.223% |
| Hyperfine, Inc. | 4.75 Million USD | 62.014% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 98.311% |
| Biomerica, Inc. | 611 Thousand USD | -195.745% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 95.665% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 331.383% |
| Silk Road Medical, Inc | 127.08 Million USD | 98.578% |